Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2015, 1-10
Abstract
Pulmonary fibrosis (PF) is a serious chronic lung disease with unknown pathogenesis. Researches have confirmed that oxidative stress which is regulated by NADPH oxidase-4 (NOX4), a main source of reactive oxygen species (ROS), is an important molecular mechanism underlying PF. Previous studies showed that total glucosides of Danggui Buxue Tang (DBTG), an extract from a classical traditional Chinese herbal formula, Danggui Buxue Tang (DBT), attenuated bleomycin-induced PF in rats. However, the mechanisms of DBTG are still not clear. We hypothesize that DBTG attenuates PF through regulating the level of oxidative stress by inhibiting NOX4. And we found that fibrosis indexes hydroxyproline (HYP) and type I collagen (Col-I) were lower in DBTG groups compared with the model group. In addition, the expression of transforming growth factor-β1 (TGF-β1) and expression of alpha smooth muscle actin (α-SMA) were also much more decreased than the model group. For oxidative stress indicators, DBTG blunted the decrease of superoxide dismutase (SOD) activity, total antioxidant capacity (T-AOC), and the increase in malondialdehyde (MDA), 8-iso-prostaglandin in lung homogenates. Treatment with DBTG restrained the expression of NOX4 compared to the model group. Present study confirms that DBTG inhibits BLM-induced PF by modulating the level of oxidative stress via suppressing NOX4.Keywords
Funding Information
- National Natural Science Foundation of China (81473267, 81274172, 30801535, 2012zy53)
- National Natural Science Foundation of China (81473267, 81274172, 30801535, 2012zy53)
- National Natural Science Foundation of China (81473267, 81274172, 30801535, 2012zy53)
- Health Department of Anhui Province (81473267, 81274172, 30801535, 2012zy53)
This publication has 22 references indexed in Scilit:
- An Inhibitor of NADPH Oxidase-4 Attenuates Established Pulmonary Fibrosis in a Rodent Disease ModelAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review, 2012
- Current and novel drug therapies for idiopathic pulmonary fibrosisDrug Design, Development and Therapy, 2012
- Molecular and cellular mechanisms of pulmonary fibrosisFibrogenesis & Tissue Repair, 2012
- Oxidative stress in health and disease: The therapeutic potential of Nrf2 activationMolecular Aspects of Medicine, 2011
- Oxidative stress contributes to the induction and persistence of TGF-β1 induced pulmonary fibrosisThe International Journal of Biochemistry & Cell Biology, 2011
- Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosisFree Radical Biology and Medicine, 2010
- Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injuryNature Medicine, 2009
- Oxidant–Antioxidant Imbalance as a Potential Contributor to the Progression of Human Pulmonary FibrosisAntioxidants & Redox Signaling, 2008